OPY Stock Recent News

Carvana Co (NYSE: CVNA) has already rallied some 100% over the past three months – but an Oppenheimer analyst believes it still has significant further room to the upside.

Spotify Technology S.A. has received a vote of confidence from Oppenheimer, with the firm citing the streaming giant's strong subscriber growth, expanding profit margins, and underutilized monetization channels as key drivers of long-term revenue expansion.

Jason Helfstein, Oppenheimer senior internet analyst, joins 'Money Movers' to discuss his takeaways from Netflix's q2 earnings.

DENVER--(BUSINESS WIRE)--CSG® (NASDAQ: CSGS) today announced that the company will present at Oppenheimer's 28th Annual Technology, Internet & Communications Conference on Monday, August 11th. The presentation will be held at 1:15 p.m. EST and will feature comments from CSG Chief Executive Officer Brian Shepherd. The conference presentation will be available via webcast here. About CSG CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to c.

Coinbase Global is facing what analysts at Oppenheimer describe as an “unfavorable” setup heading into its second-quarter earnings report, with trading volumes and revenues expected to fall short of Wall Street estimates. The cryptocurrency exchange is projected to post a significant sequential drop in trading activity, despite its stock having more than doubled this year.

Veteran Dealmaker Brings More Than 25 Years of Healthcare Industry Experience NEW YORK , July 14, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY), announced today the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson will report to Michael Margolis, R.Ph.

Brian Schwartz, Oppenheimer analyst, joins 'Closing Bell Overtime' to talk Microsoft hitting record highs and why he is still bullish on the stock to continue higher from here.

Oppenheimer has upgraded Microsoft (NASDAQ: MSFT) to Outperform from Perform, setting a price target of $600 per share- a nearly 21% increase from the company's closing price on Tuesday. The firm believes Microsoft's long-term potential in artificial intelligence (AI) is still not fully reflected in its stock price.

CNBC's “Closing Bell” is joined by Oppenheimer's Brian Nagel to get his reaction to Nike's fiscal fourth-quarter earnings report.

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will participate in a panel discussion at the Oppenheimer Innovators in Immunology & Inflammation (I&I) Summit on June 25 in New York, NY. Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a panel titled, “Advances in Dermatology: AD and CSU” on Wednesday, June 25 at 10:.